Functional interference of SP1 and NF-κB through the same DNA binding site

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1266-1274

  Hirano, Fuminori ^a   Tanaka, Hirotoshi ^b   Hirano, Yoshiko ^a   Hiramoto, Masaki ^c   Handa, Hiroshi ^c   Makino, Isao ^b   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; PADGEM PROTEIN; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; DISSOCIATION CONSTANT; DNA BINDING; DROSOPHILA; ELECTROPHORETIC MOBILITY; GENE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL;

EID: 0031935038     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1266     Document Type: Article

References (67)

1. Augustin, L. B., R. F. Felsheim, B. H. Min, S. M. Fuchs, J. A. Fuchs, and H. H. Loh. 1995. Genomic structure of the mouse delta opioid receptor gene. Biochem. Biophys. Res. Commun. 207:111-119.
2. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13-20.
3. Ballard, D. W., E. Bohnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241:1652-1655.
4. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
5. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
6. Berg, J. M. 1992. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. USA 89:11109-11110.
7. Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234:47-52.
8. Bucher, P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:563-578.
9. Courey, A. J., and R. Tjian. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
10. Courey, A. J., D. A. Holtzman, S. P. Jackson, and R. Tjian. 1989. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59:827-836.
11. Courey, A. J., and R. Tjian. 1992. Mechanism of transcriptional control as revealed by studies of human transcription factor Sp1, p. 743-769. In K. R. Yamamoto and S. L. McKnight (ed.), Transcriptional regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
12. Daniel, S., S. Zhang, A. A. DePaoli-Roach, and K. H. Kim. 1996. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 271:14692-14697.
13. Demczuk, S., M. Harbers, and B. Vennstrom. 1993. Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. Proc. Natl. Acad. Sci. USA 90:2574-2578.
14. Fan, C. M., and T. Maniatis. 1990. A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence. Genes Dev. 4:29-42.
15. Fujita, T., G. P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev. 6:775-787.
16. Ghosh, G., G. van Duyne, S. Ghosh, and P. B. Sigler. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373:303-310.
17. Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in an multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
18. Hagen, G., S. Muller, M. Beato, and G. Suske. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:3843-3851.
19. Hagen, G., J. Dennig, A. Preiss, M. Beato, and G. Suske. 1995. Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J. Biol. Chem. 270:24989-24994.
20. Harrington, M. A., P. A. Jones, M. Imagawa, and M. Karin. 1988. Cytosine methylation does not affect binding of transcription factor Sp1. Proc. Natl. Acad. Sci. USA 85:2066-2070.
21. Hirano, F., H. Tanaka, Y. Makino, K. Okamoto, M. Hiramoto, H. Handa, and I. Makino. 1996. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17:427-433.
22. Imataka, H., K. Sogawa, K. Yasumoto, Y. Kikuchi, K. Sasano, A. Kobayashi, M. Hayami and Y. Fujii-Kuriyama. 1992. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 11:3663-3671.
23. Jones, K. A., J. T. Kadonaga, P. A. Luciw, and R. Tjian. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232:755-759.
24. Jones, P. L., G. Kucera, H. Gordon, and J. M. Boss. 1995. Cloning and characterization of the murine manganous superoxide dismutase-encoding gene. Gene 153:155-161.
25. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
26. Kannabiran, C., X. Zeng, and L. D. Vales. 1997. The mammalian transcriptional repressor RBP CBF1 regulates interleukin-6 gene expression. Mol. Cell. Biol. 17:1-9.
27. Kerr, L. D., L. J. Ransone, P. Wamsley, M. J. Schmitt, T. G. Boyer, Q. Zhou, A. J. Berk, and I. M. Verma. 1993. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature 365:412-419.
28. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation humoral immunity and interleukin-2 expression. Genes Dev. 9:1965-1977.
29. Krappman, D., F. G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15:6716-6726.
30. Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R. G. Roeder. 1992. Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev. 6:761-774.
31. Kriwacki, R. V., S. C. Schultz, T. M. Steitz, and J. P. Caradonna. 1992. Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc. Natl. Acad. Sci. USA 89:9759-9763.
32. Letovsky, J., and W. S. Dynan. 1989. Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucleic Acids Res. 17:2639-2653.
33. Lombardi, L., P. Ciana, C. Cappellini, D. Trecca, L. Guerrini, A. Migliazza, A. T. Maiolo, and A. Neri. 1995. Structural and functional characterization of the promoter regions of the NFKB2 gene. Nucleic Acids Res. 23:2328-2336.
34. 62 in DNA recognition by the P50 subunit of NF-κB. Nucleic Acids Res. 21:1727-1734.
35. Meisterernst, M., I. Gander, L. Rogge, and E.-L. Winnacker. 1988. A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res. 16:4419-4435.
36. Moll, T., M. Czyz, H. Holzmuller, R. Hofer-Warbinek, E. Wagner, H. Winkler, F. H. Bach, and E. Hofer. 1995. Regulation of the tissue factor promoter in endothelial cells. Binding of NF-κB-, AP-1-, and Sp1-like transcription factors. J. Biol. Chem. 270:3849-3857.
37. Muchardt, C., J. S. Seeler, A. Nirula, D. L. Shurland, and R. B. Gaynor. 1992. Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products. J. Virol. 66:244-250.
38. Muller, C. W., F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373:311-317.
39. Naumann, M., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607.
40. Naumann, M., F. G. Wulczyn, and C. Scheidereit. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J. 12:213-222.
41. Neish, A. S., A. J. Williams, H. J. Palmer, M. Z. Whitley, and T. Collins. 1992. Functional analysis of the human vascular cell adhesion molecules 1 promoter. J. Exp. Med. 176:1583-1593.
42. Pan, J., and R. P. McEver. 1995. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J. Biol. Chem. 270:23077-23083.
43. Pavletich, N. P., and C. O. Pabo. 1991. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252:809-817.
44. Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37-49.
45. Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NFκB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558.
46. Perkins, N. D., A. B. Agranoff, E. Pascal, and G. J. Nabel. 1994. An interaction between the DNA-binding domains of RelAp65 and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14:6570-6583.
47. Rokaeus, A., and J. A. Waschek. 1994. Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. DNA Cell Biol. 8:845-855.
48. Roman, D. G., M. B. Toledano, and W. J. Leonard. 1990. Sp1 represses IL-2 receptor alpha chain gene expression. New Biol. 2:642-647
49. Saffer, J. D., S. P. Jackson, and M. B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11:2189-2199.
50. Sanceau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF-κB, and Sp1 transcription factors. J. Biol. Chem. 270:27920-27931.
51. Scheidereit, C., D. Krappmann, and F. G. Wulczyn. 1996. Regulation of the NF-κB family of transcriptions factors by protein phosphorylation, p. 163-196. In M. Clemens (ed.), Protein phosphorylation and cell growth regulation. Harwood Academic Publishers, Amsterdam, The Netherlands.
52. Shirakata, Y., J. D. Shuman, and J. E. Coligan. 1996. Purification of a novel MHC class I element binding activity from thymus nuclear extracts reveals that thymic RBP-Jκ/CBF1 binds to NF-κB-like elements. J. Immunol. 156:4672-4679.
53. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
54. Sif, S., and T. D. Gilmore. 1994. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J. Virol. 68:7131-7138.
55. Stade, B. G., G. Messer, G. Riethmuller, and J. P. Johnson. 1990. Structural characteristics of the 5′ region of the human ICAM-1 gene. Immunobiology 182:79-87.
56. Sugimoto, K., A. Tsuboi, S. Miyatake, K. Arai, and N. Arai. 1990. Inducible and non-inducible factors co-operatively activate the GM-CSF promoter by interacting with two adjacent DNA motifs. Int. Immunol. 2:787-794.
57. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG IY is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777-789.
58. Tjian, R., and T. Maniatis. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8.
59. Ueberla, K., Y. C. Lu, E. Chung, and W. A. Haseltine. 1993. The NF-βB p65 promoter. J. AIDS Res. 6:227-230.
60. Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, S. Kawamoto, Y. Ishigatsubo, and T. Okubo. 1994. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:2052-2063.
61. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
62. Viswanathan, M., M. Yu, L. Mendoza, and J. J. Yunis. 1996. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter. Gene 170:271-276.
63. Vlach, J., A. Garcia, J.-M. Jacque, M. S. Rodriguez, S. Michelson, and J.-L. Virelizier. 1995. Induction of Sp1 phosphorylation and NF-κB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 208:753-761.
64. Wood, L. D., A. A. Farmer, and A. Richmond. 1995. HMGIY and Sp1 in addition to NF-κB regulate transcription of the MGSA/GROα gene. Nucleic Acids Res. 23:4210-4219.
65. Wulczyn, F. G., D. Krappmann, and C. Scheidereit. 1996. The NF-κB and IκB gene families: mediators of immune response and inflammation. J. Mol. Med. 74:749-769.
66. Yurochko, A. D., T. F. Kowalik, S.-M. Huong, and E.-S. Huang. 1995. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
67. 2+ dependence and differential half-site recognition. J. Biol. Chem. 266:252-260.